The Welch Allyn RV100-B Handheld RetinaVue 100 Imager Non-Mydriatic Retinal Camera is designed to provide a truly cost-saving solution and an effective tool for diabetic retinopathy screening. It is a handheld fundus camera very simple to handle and convenient in use.
The implementation of a breakthrough technology has resulted in a compact, yet highly functional devise allowing for efficient early detection of diabetic retinopathy, vital for the prevention of vision loss. The Camera is specifically designed for convenient hand holding and its light weight of 1.25 lbs promotes use comfort and excellent portability. This 100 Imager helps facilitate a non-mydriatic eye exam allowing for enhanced patient comfort. The touchless auto-focus function and image capture support along with the automatic evaluation of the acquired image help ensure the acquisition of a high-quality test results. The camera is assembled with a large full color TFT-LCD monitor measuring 3.5"" that displays fundus during the screening process and provides 45 degree field of view.
RetinaVue™ Non-Mydriatic Camera comprises a great number of advanced features that ensure dependable service and test precision. It is assembled with LED lights for infrared illumination in preview mode and natural white color in image capture mode. 1920 × 1080 pixels camera resolution ensures the acquisition of a sharp image that can be saved in JPEG or DICOM formats. The Camera is powered by a rechargeable lithium battery that provides operating time capacity of 3 hours and five-hour charging time.
100 Imager is designed specifically to work with RetinaVue Network that promotes advanced data management, facilitating easy image review, transfer, expert diagnostic interpretation and reporting. Connection to a PC is exerted via Micro USB interface while the unit supports 2 G to 32 GB SD cards for data storage. Within only a few minutes 100 Imager acquires sharp, non-mydriatic fundus images and facilitates the test results transfer via secure HIPAA-compliant RetinaVue Network. The image diagnostics is realized by a board-certified retinal specialist. The diagnostic report and referral/screening plan are delivered the same day or normally within as little as 90 minutes.
Studies show that with RetinaVue Network your patient compliance rates can double in 12 moths, while most top healthcare plans reimburse for testing and provide coverage specifically for RetinaVue diabetic retinopathy screening.
- Double HEDIS/STARS compliance rates for diabetic retinal assessment in 12 months
- Most top healthcare plans now reimburse for retinal screenings
- Simple four-step process is effective and affordable
- Same day diagnostic report—usually in 90 minutes
- Like adding a retinal specialist to your team